Toward more accurate pan-specific MHC-peptide binding prediction: A review of current methods and tools

Briefings in Bioinformatics

Volumn 13, Issue 3, 2012, Pages 350-364

  Zhang, Lianming ^a   Udaka, Keiko ^b   Mamitsuka, Hiroshi ^c   Zhu, Shanfeng ^a  

^a FUDAN UNIVERSITY   (China)

^b KOCHI MEDICAL SCHOOL   (Japan)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

Immunoinformatics; MHC peptide binding prediction; Pan specific

Indexed keywords

EID: 83155180577     PISSN: 14675463     EISSN: 14774054     Source Type: Journal    
DOI: 10.1093/bib/bbr060     Document Type: Review

References (69)

1. Janeway CA, Travers P, Walport M, et al. Immunobiology: the Immune System in Health and Disease. 6th edn. New York: Garland Science Publishing, 2005.
2. Lund O, Nielsen M, Lundegaard C, et al. Immunological Bioinformatics. Cambridge, MA: The MIT Press, 2005.
3. Purcell AW, McCluskey J, Rossjohn J. More than one reason to rethink the use of peptides in vaccine design. Nat RevDrug Discov 2007;6(5):404-14.
4. Voutsas IF, Gritzapis AD, Mahaira LG, et al. Induction of potent CD4{thorn} T cell-mediated antitumor responses by a helper HER-2/neu peptide linked to the Ii-Key moiety of the invariant chain. IntJCancer 2007;121(9):2031-41.
5. Kong YC, Flynn JC, Banga JP, et al. Application of HLA class II transgenic mice to study autoimmune regulation. Thyroid 2007;17(10):995-1003.
6. Rhyner C, Kündig T, Akdis CA, et al. Targeting the MHC II presentation pathway in allergy vaccine development. Biochem SocTrans 2007;35(Pt 4):833-4.
7. Abbas AK, Lichtman AH. Chapter 3: antigen capture and presentation to lymphocytes. Basic Immunology: Functions and Disorders of the Immune System. 3rd edn. Philadelphia: Elsevier, 2009.
8. Assarsson E, Sidney J, Oseroff C, etal. A quantitative analysis of the variables affecting the repertoire of T cell specificities recognized after vaccinia virus infection. J Immunol 2007; 178(12):7890-901.
9. Robinson J, Mistry K, McWilliam H, et al. The IMGT/ HLA database. Nucleic Acids Res 2011;39(Database issue): D1171-6.
10. Yewdell JW, Bennink JR. Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses. Annu rev immunol 1999;17:51-88.
11. Tong JC, Tan TW, Ranganathan S. Methods and protocols for prediction of immunogenic epitopes. Brief Bioinform 2007;8(2):96-108.
12. Buus S, Lauemoller SL, Worning P, et al. Sensitive quantitative predictions of peptide-MHC binding by a 'Query by Committee' artificial neural network approach. Tissue Antigens 2003;62(5):378-84.
13. Nielsen M, Lundegaard C, Worning P, et al. Reliable prediction of T-cell epitopes using neural networks with novel sequence representations. ProteinSci 2003;12(5):1007-17.
14. Peters B, Sette A. Generating quantitative models describing the sequence specificity of biological processes with the stabilized matrix method. BMC Bioinformatics 2005;6:132.
15. Zhang Q, Wang P, Kim Y, et al. Immune epitope database analysis resource (IEDB-AR). Nucleic Acids Res 2008; 36(Web Server issue):W513-8.
16. El-Manzalawy Y, Dobbs D, Honavar V. Predicting MHC-II binding affinity using multiple instance regression. IEEE/ACMTrans Comput Biol Bioinform 2011;8(4):1067-79.
17. Nielsen M, Lundegaard C, Lund O. Prediction of MHC class II binding affinity using SMM-align, a novel stabilization matrix alignment method. BMC Bioinformatics 2007;8:238.
18. Nielsen M, Lund O. NN-align. An artificial neural network-based alignment algorithm for MHC class II peptide binding prediction. BMC Bioinformatics 2009;10: 296.
19. Bordner AJ, Mittelmann HD. Prediction of the binding affinities of peptides to class II MHC using a regularized thermodynamic model. BMC Bioinformatics 2010;11:41.
20. Wang P, Sidney J, Kim Y, et al. Peptide binding predictions for HLA DR, DP and DQ molecules. BMC Bioinformatics 2010;11:568.
21. Vita R, Zarebski L, Greenbaum JA, et al. The immune epitope database 2.0. Nucleic Acids Res 2010;38:D854-62.
22. Jojic N, Reyes-Gomez M, Heckerman D, et al. Learning MHC I-peptide binding. Bioinformatics 2006;22(14): e227-35.
23. Jacob L, Vert JP. Efficient peptide-MHC-I binding prediction for alleles with few known binders. Bioinformatics 2008; 24(3):358-66.
24. Nielsen M, Lundegaard C, Blicher T, et al. NetMHCpan, a method for quantitative predictions of peptide binding to any HLA-A and -B locus protein of known sequence. PLoS One 2007;2(8):e796.
25. Hoof I, Peters B, Sidney J, et al. NetMHCpan, a method for MHC class I binding prediction beyond humans. Immunogenetics 2009;61(1):1-13.
26. Zhang H, Lund O, Nielsen M. The PickPocket method for predicting binding specificities for receptors based on receptor pocket similarities: application to MHC-peptide binding. Bioinformatics 2009;25(10):1293-9.
27. Sturniolo T, Bono E, Ding J, et al. Generation of tissue-specific and promiscuous HLA ligand databases using DNA microarrays and virtual HLA class II matrices. Nat Biotechnol 1999;17:555-61.
28. Singh H, Raghava GP. ProPred: prediction of HLA-DR binding sites. Bioinformatics 2001;17(12):1236-7.
29. Pfeifer N, Kohlbacher O. Multiple instance learning allows MHC class II epitope predictions across Alleles. Proceedings of the 8th International Workshop on Algorithms in Bioinformatics. Germany: Karlsruhe, 2008;210-221.
30. Zaitlen N, Reyes-Gomez M, Heckerman D, et al. Shift-invariant adaptive double threading: learning MHC II-peptide binding. JComputBiol 2008;15(7):927-42.
31. Bordner AJ, Mittelmann HD. MultiRTA: a simple yet reliable method for predicting peptide binding affinities for multiple class II MHC allotypes. BMC Bioinformatics 2010; 11:482.
32. Nielsen M, Lundegaard C, Blicher T, et al. Quantitative predictions of peptide binding to any HLA-DR molecule of known sequence: NetMHCIIpan. PLoS Comput Biol 2008;4(7):e1000107.
33. Nielsen M, Justesen S, Lund O, et al. NetMHCIIpan-2.0 -improved pan-specific HLA-DR predictions using a novel concurrent alignment and weight optimization training procedure. ImmunomeRes 2010;6:9.
34. Zhang GL, Deluca DS, Keskin DB, et al. MULTIPRED2: a computational system for large-scale identification of peptides predicted to bind to HLA supertypes and alleles. J Immunol Methods 2010. http://www.sciencedirect.com/ science/article/pii/S0022175910003455.
35. Brusic V, Petrovsky N, Zhang G, Bajic VB. Prediction of promiscuous peptides that bind HLA class I molecules. Immunol Cell Biol 2002;80(3):280-5.
36. Zhang GL, Khan AM, Srinivasan KN, et al. MULTIPRED: a computational system for prediction of promiscuous HLA binding peptides. Nucleic Acids Res 2005;33(Web Server issue):W172-9.
37. Sette A, Sidney J. Nine major HLA class I supertypes account for the vast preponderance of HLA-A and -B polymorphism. Immunogenetics 1999;50:201-12.
38. Rammensee HG, Falk K, Rotzschke O. Peptides naturally presented by MHC class I molecules. Annu Rev Immunol 1993;11:213-44.
39. Lippolis JD, White FM, Marto JA, et al. Analysis of MHC class II antigen processing by quantitation of peptides that constitute nested sets. J Immunol 2002;169(9):5089-97.
40. The PyMOL Molecular Graphics System, Version 1.3, Schrödinger, LLC.
41. Berman HM, Battistuz T, Bhat TN, et al. The protein data bank. Acta Crystallogr DBiol Crystallogr 2002;58:899-907.
42. Rammensee H, Bachmann J, Emmerich NP, et al. SYFPEITHI: database for MHC ligands and peptide motifs. Immunogenetics 1999;50:213-9.
43. Reche PA, Reinherz EL. PEPVAC: a web server for multi-epitope vaccine development based on the prediction of supertypic MHC ligands. Nucleic Acids Res 2005;33(Web Server issue):W138-42.
44. Stranzl T, Larsen MV, Lundegaard C, Nielsen M. NetCTLpan: pan-specific MHC class I pathway epitope predictions. Immunogenetics 2010;62(6):357-68.
45. Larsen MV, Lundegaard C, Lamberth K, et al. Large-scale validation of methods for cytotoxic T-lymphocyte epitope prediction. BMC Bioinformatics 2007;8:424.
46. Tenzer S, Peters B, Bulik S, et al. Modeling the MHC class I pathway by combining predictions of proteasomal cleavage, TAP transport and MHC class I binding. Cell Mol Life Sci 2005;62(9):1025-37.
47. Nielsen M, Lundegaard C, Lund O, Keşmir C. The role of the proteasome in generating cytotoxic T-cell epitopes: insights obtained from improved predictions of proteasomal cleavage. Immunogenetics 2005;57(1-2):33-41.
48. Peters B, Bulik S, Tampe R, et al. Identifying MHC class I epitopes by predicting the TAP transport efficiency of epitope precursors. J Immunol 2003;171(4):1741-9.
49. Lafuente EM, Reche PA. Prediction of MHC-peptide binding: a systematic and comprehensive overview. Curr PharmDes 2009;15(28):3209-20.
50. Lin HH, Ray S, Tongchusak S, et al. Evaluation of MHC class I peptide binding prediction servers: applications for vaccine research. BMCImmunol 2008;9:8.
51. El-Manzalawy Y, Dobbs D, Honavar V. On evaluating MHC-II binding peptide prediction methods. PLoS One 2008;3(9):e3268.
52. Lin HH, Zhang GL, Tongchusak S, et al. Evaluation of MHC-II peptide binding prediction servers: applications for vaccine research. BMC Bioinformatics 2008; 9(Suppl. 12):S22.
53. Wang P, Sidney J, Dow C. A systematic assessment of MHC class II peptide binding predictions and evaluation of a consensus approach. PLoS Comput Biol 2008;4(4): e1000048.
54. Peters B, Bui HH, Frankild S, et al. A community resource benchmarking predictions of peptide binding to MHC-I molecules. PLoSComput Biol 2006;2:e65.
55. Zhang H, Lundegaard C, Nielsen M. Pan-specific MHC class I predictors: a benchmark of HLA class I pan-specific prediction methods. Bioinformatics 2009;25(1):83-9.
56. Lundegaard C, Lund O, Buus S, et al. Major histocompatibility complex class I binding predictions as a tool in epitope discovery. Immunology 2010;130(3):309-18.
57. Nielsen M, Lund O, Buus S, et al. MHC class II epitope predictive algorithms. Immunology 2010;130(3):319-28.
58. Lundegaard C, Hoof I, Lund O, et al. State of the art and challenges in sequence based T-cell epitope prediction. ImmunomeRes 2010;6(Suppl. 2):S3.
59. Swets JA. Measuring the accuracy of diagnostic systems. Science 1988;240:1285-93.
60. Press WH, Teukolsky SA, Vetterling WT, et al. Numerical Recipes in C: The Art of Scientific Computing. Cambridge: Cambridge University Press, 1992.
61. Robinson J, Mistry K, McWilliam H, et al. IPD-the immuno polymorphism database. Nucleic Acids Res 2010; 38(Database issue):D863-9.
62. Lata S, Bhasin M, Raghava GP. MHCBN 4.0: a database of MHC/TAP binding peptides and T-cell epitopes. BMCRes Notes 2009;2:61.
63. Reche PA, Zhang H, Glutting JP, et al. EPIMHC: a curated database of MHC-binding peptides for customized computational vaccinology. Bioinformatics 2005;21:2140-1.
64. Heckerman D, Kadie C, Listgarten J. Leveraging information across HLA alleles/super-types improves HLA-specific epitope prediction. JComputBiol 2007;14(6):736-46.
65. The UniProt Consortium. The universal protein resource (UniProt). Nucleic Acids Res 2008;36(Database issue): D190-5.
66. Jain A, Nandakumar K, Ross A. Score normalization in multimodal biometric systems. Pattern Recognit 2005;38(12): 2270-85.
67. Karpenko O, Huang L, Dai Y. A probabilistic metapredictor for the MHC class II binding peptides. Immunogenetics 2008;60:25-36.
68. Hu X, Mamitsuka H, Zhu S. Ensemble approaches for improving HLA class I-peptide binding prediction. J Immunol Methods 2010. http://www.sciencedirect.com/science/ article/pii/S0022175910002619.
69. Hu X, Zhou W, Udaka K, et al. MetaMHC: a meta approach to predict peptides binding to MHC molecules. Nucleic Acids Res 2010;38:W474-9.